DeAnn Smith recently shared her perspective on how artificial intelligence is changing the intellectual property landscape for drug patents in the
STAT article “How AI may create new battles over drug patents."
Smith highlighted three key areas in which AI has already had, and will continue to have, an impact on securing patents: inventorship, written description and enablement, and non-obviousness.
Read the full article
here (subscription may be required).